Not investment advice. Educational platform. See Disclaimer.
NASDAQ: ACON
Aclarion, Inc.
Healthcare | Medical - Healthcare Information Services
$2.94-0.09 (-2.97%)as of 2026-07-15 02:05 UTC
Volume22.3K
EPS (TTM)$-13.61
Aclarion, Inc. (NASDAQ: ACON) is a medical - healthcare information services company trading at $2.94 (−3.0% today). Figures from SEC EDGAR and market feeds; updated 2026-07-15 02:05 UTC.
52-Week Range
Low $2.34High $12.03
What Aclarion, Inc. does
Aclarion is a healthcare technology company that uses Magnetic Resonance Spectroscopy (MRS) to identify which spinal discs are causing pain in patients with chronic low back and neck pain. The company has developed proprietary signal processing software and biomarkers licensed from UCSF that convert MRS data into chemical information about disc composition, which its algorithms use to determine if a disc is consistent with pain.
Pre-revenue, development-stage company: standard profitability ratios (P/E, EV/EBITDA, ROE) do not apply yet because there are no earnings. Watch cash, cash runway, net loss, R&D spend and share dilution instead.
Aclarion is a healthcare technology company that uses Magnetic Resonance Spectroscopy (MRS) to identify which spinal discs are causing pain in patients with chronic low back and neck pain.
What is ACON's valuation?
ACON trades at $2.94, as of 2026-07-15.
When did ACON last file with the SEC?
Aclarion, Inc.'s most recent SEC filing on record is a 8-K filed 2026-06-04. All filings link to their SEC EDGAR originals above.
Where does this data come from?
SEC EDGAR filings and public market data feeds, fetched 2026-07-15 02:05 UTC. This page is also available as JSON at /api/data?ticker=ACON and is emitted with FAQPage structured data for machine reading.
For you
Charts, 10-year financials, peer comparison, screening and portfolio tracking for ACON and 3,500+ tickers.
